In a filing, Neurocrine Biosciences, Inc. revealed its Chief Legal Officer Lippoldt Darin unloaded Company’s shares for reported $1.05 million on Jul 16 ’24. In the deal valued at $150.00 per share,7,004 shares were sold. As a result of this transaction, Lippoldt Darin now holds 39,740 shares worth roughly $6.09 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Delaet Ingrid sold 2,857 shares, generating $428,627 in total proceeds. Upon selling the shares at $150.03, the Chief Regulatory Officer now owns 6,607 shares.
Before that, LYONS GARY A sold 930 shares. Neurocrine Biosciences, Inc. shares valued at $139,530 were divested by the Director at a price of $150.03 per share. As a result of the transaction, LYONS GARY A now holds 119,047 shares, worth roughly $18.23 million.
Wells Fargo upgraded its Neurocrine Biosciences, Inc. [NBIX] rating to an Overweight from a an Equal weight in a research note published on April 24, 2024; the price target was increased to $170 from $140. Deutsche Bank began covering NBIX with “Buy” recommendation on December 12, 2023.
Price Performance Review of NBIX
On Friday, Neurocrine Biosciences, Inc. [NASDAQ:NBIX] saw its stock fall -0.01% to $153.14. Over the last five days, the stock has gained 4.32%. Neurocrine Biosciences, Inc. shares have risen nearly 16.23% since the year began. Nevertheless, the stocks have risen 47.05% over the past one year. While a 52-week high of $157.98 was reached on 08/01/24, a 52-week low of $100.52 was recorded on 02/07/24. SMA at 50 days reached $140.04, while 200 days put it at $132.28. A total of 0.8 million shares were traded, compared to the trading of 2.03 million shares in the previous session.
Levels Of Support And Resistance For NBIX Stock
The 24-hour chart illustrates a support level at 150.51, which if violated will result in even more drops to 147.87. On the upside, there is a resistance level at 156.59. A further resistance level may holdings at 160.03. The Relative Strength Index (RSI) on the 14-day chart is 67.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.16, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 24.37%. Stochastics%K at 59.81% indicates the stock is a holding.
The most recent change occurred on August 21, 2023 when Mizuho resumed its ‘”a Neutral”‘ rating for the stock and retained the price target to $113.
